Cargando…

NLRP1 promotes tumor growth by enhancing inflammasome activation and suppressing apoptosis in metastatic melanoma

Inflammasomes are mediators of inflammation, and constitutively activated NLRP3 inflammasomes have been linked to IL-1β-mediated tumorigenesis in human melanoma. Whereas NLRP3 regulation of caspase-1 activation requires the adaptor protein ASC, caspase-1 activation by another danger-signaling sensor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhai, Zili, Liu, Weimin, Kaur, Manjinder, Luo, Yuchun, Domenico, Joanne, Samson, Jenny Mae, Shellman, Yiqun G, Norris, David A, Dinarello, Charles A, Spritz, Richard A, Fujita, Mayumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5501746/ https://www.ncbi.nlm.nih.gov/pubmed/28263976 http://dx.doi.org/10.1038/onc.2017.26

Ejemplares similares

Inflammasome Sensor NLRP1 Confers Acquired Drug Resistance to Temozolomide in Human Melanoma
por: Zhai, Zili, et al.
Publicado: (2020)

NLRP1 Functions Downstream of the MAPK/ERK Signaling via ATF4 and Contributes to Acquired Targeted Therapy Resistance in Human Metastatic Melanoma
por: Zhai, Zili, et al.
Publicado: (2020)

Computational Modeling of NLRP3 Identifies Enhanced ATP Binding and Multimerization in Cryopyrin-Associated Periodic Syndromes
por: Samson, Jenny Mae, et al.
Publicado: (2020)

Dual role of apoptosis-associated speck-like protein containing a CARD (ASC) in tumorigenesis of human melanoma
por: Liu, Weimin, et al.
Publicado: (2012)

Alternative treatments for melanoma: targeting BCL-2 family members to de-bulk and kill cancer stem cells
por: Mukherjee, Nabanita, et al.
Publicado: (2015)

Combining a BCL2 Inhibitor with the Retinoid Derivative Fenretinide Targets Melanoma Cells Including Melanoma Initiating Cells
por: Mukherjee, Nabanita, et al.
Publicado: (2014)

ABT-737 synergizes with Bortezomib to kill melanoma cells
por: Reuland, Steven N., et al.
Publicado: (2011)

Use of a MCL-1 inhibitor alone to de-bulk melanoma and in combination to kill melanoma initiating cells
por: Mukherjee, Nabanita, et al.
Publicado: (2016)

The Combination of BH3-Mimetic ABT-737 with the Alkylating Agent Temozolomide Induces Strong Synergistic Killing of Melanoma Cells Independent of p53
por: Reuland, Steven N., et al.
Publicado: (2011)

Enrichment of Melanoma Stem-Like Cells via Sphere Assays
por: Mukherjee, Nabanita, et al.
Publicado: (2021)

Combining a GSI and BCL-2 inhibitor to overcome melanoma's resistance to current treatments
por: Mukherjee, Nabanita, et al.
Publicado: (2016)

Side Population Cells from Human Melanoma Tumors Reveal Diverse Mechanisms for Chemoresistance
por: Luo, Yuchun, et al.
Publicado: (2012)

Ethanol Metabolism and Melanoma
por: Zhai, Zili, et al.
Publicado: (2023)

MCL1 inhibitors S63845/MIK665 plus Navitoclax synergistically kill difficult-to-treat melanoma cells
por: Mukherjee, Nabanita, et al.
Publicado: (2020)

OLT1177 (Dapansutrile), a Selective NLRP3 Inflammasome Inhibitor, Ameliorates Experimental Autoimmune Encephalomyelitis Pathogenesis
por: Sánchez-Fernández, Alba, et al.
Publicado: (2019)

The NLRP3 inflammasome – interleukin 1β axis in uveal melanoma
por: Correa, Victor S. M. C., et al.
Publicado: (2023)

Ellagic acid inhibits melanoma growth in vitro
por: Jensen, J. Daniel, et al.
Publicado: (2011)

The NLRP6 inflammasome
por: Zheng, Danping, et al.
Publicado: (2020)

Simultaneously Inhibiting BCL2 and MCL1 Is a Therapeutic Option for Patients with Advanced Melanoma
por: Mukherjee, Nabanita, et al.
Publicado: (2020)

The NLRP3 inflammasome inhibitor OLT1177 rescues cognitive impairment in a mouse model of Alzheimer’s disease
por: Lonnemann, Niklas, et al.
Publicado: (2020)

NLRP3 inflammasome inhibitor OLT1177 suppresses joint inflammation in murine models of acute arthritis
por: Marchetti, Carlo, et al.
Publicado: (2018)

The linear ubiquitin assembly complex (LUBAC) is essential for NLRP3 inflammasome activation
por: Rodgers, Mary A., et al.
Publicado: (2014)

The NLRP1 and CARD8 inflammasomes
por: Taabazuing, Cornelius Y., et al.
Publicado: (2020)

Neurodegenerative Disease and the NLRP3 Inflammasome
por: Holbrook, Jonathan A., et al.
Publicado: (2021)

Myeloid-derived miR-223 regulates intestinal inflammation via repression of the NLRP3 inflammasome
por: Neudecker, Viola, et al.
Publicado: (2017)

A simple technique for quantifying apoptosis in 96-well plates
por: Ribble, Deborah, et al.
Publicado: (2005)

Inhibiting the NLRP3 Inflammasome
por: El-Sharkawy, Lina Y., et al.
Publicado: (2020)

Targeting tumor-derived NLRP3 reduces melanoma progression by limiting MDSCs expansion
por: Tengesdal, Isak W., et al.
Publicado: (2021)

NLRP3 inflammasome is expressed and regulated in human islets
por: Lebreton, Fanny, et al.
Publicado: (2018)

Activation of Host-NLRP3 Inflammasome in Myeloid Cells Dictates Response to Anti-PD-1 Therapy in Metastatic Breast Cancers
por: Tengesdal, Isak W., et al.
Publicado: (2022)

NLRP3 licenses NLRP11 for inflammasome activation in human macrophages
por: Gangopadhyay, Anu, et al.
Publicado: (2022)

Contribution of Nlrp3 Inflammasome Activation Mediated by Suilysin to Streptococcal Toxic Shock-like Syndrome
por: Song, Liqiong, et al.
Publicado: (2020)

A Simple Protocol for Using a LDH-Based Cytotoxicity Assay to Assess the Effects of Death and Growth Inhibition at the Same Time
por: Smith, Shilo M., et al.
Publicado: (2011)

NLRP3 Inflammasome: Activation and Regulation in Age-Related Macular Degeneration
por: Gao, Jiangyuan, et al.
Publicado: (2015)

NLRP3 Inflammasome Activation in Adipose Tissues and Its Implications on Metabolic Diseases
por: Wu, Kelvin Ka-Lok, et al.
Publicado: (2020)

Alcohol as a Non-UV Social-Environmental Risk Factor for Melanoma
por: Yamauchi, Takeshi, et al.
Publicado: (2022)

Research Progress of Mitochondrial Mechanism in NLRP3 Inflammasome Activation and Exercise Regulation of NLRP3 Inflammasome
por: Zhang, Tan, et al.
Publicado: (2021)

The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer’s disease
por: Saresella, Marina, et al.
Publicado: (2016)

The Role of Inflammasome-Dependent and Inflammasome-Independent NLRP3 in the Kidney
por: Kim, Yang Gyun, et al.
Publicado: (2019)

Vimentin regulates activation of the NLRP3 inflammasome
por: dos Santos, Gimena, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_i66sm30nbppjf5lb5k1nb7v927